Showing 11-20 results of 50 total
Cardiology and Vascular Diseases
Testing a New Treatment to Lower Heart Risks in People With High Blood Pressure
The ZENITH study aims to find out if an investigational medication, called zilebesiran (pronounced zile-BEE-siran), can help control high blood pressure and...
Diabetes|Metabolic Conditions
New investigational medication for patients with T2DM or metabolic syndrome
This study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the safety, tolerability and effectiveness of the...
Allergy, Asthma, Immunology|Blood Disorders|Hepatology|Skin Disorders
New investigational drug for indolent systemic mastocytosis
This study is testing an investigational drug called TL-895. TL-895 is a kinase inhibitor drug which may be able to reduce disease-related symptoms in...
Cardiology and Vascular Diseases
New investigational device (Reprieve system) for heart failure subjects.
The FASTR II trial will evaluate the safety and effectiveness of the Reprieve System in comparison with optimal diuretic therapy (ODT)in the treatment of...
Cancer
A Research Study of OBI-902 in Participants with Advanced Solid Tumors.
This study will evaluate the safety and tolerability of investigational drug OBI-902 in participants with advanced solid tumors. The study also aims to find...
Arthritis and Joint Disorders|Orthopedics|Pain Management|Reconstructive Surgery
Nociscan MR Spectroscopy scan in patients for Degenerative Low Back Pain
This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software tool that uses Magnetic Resonance (MR) spectroscopy Imaging. NOCISCAN...
Cancer
New study for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
This study will compare the medication Sonrotoclax plus an anti-CD20 antibody therapy versus Venetoclax plus Rituximab. Enrollment into the different study...
Cancer
New study for patients with HR+ HER2- advanced breast cancer
This is a double-blind, placebo-controlled study evaluating the efficacy and safety of Inavolisib + a CDK4/6 inhibitor and letrozole, versus placebo + a...
Cancer
New investigational drug for treatment of ovarian cancer
This study will test the safety and effectiveness of an investigational drug combined with an FDA approved dose of Bevacuzimab for ovarian cancer....
Cancer
Investigational drug for breast cancer patients with brain metastases
The purpose of this study is to evaluate the safety and effectiveness of investigational drug UTD1 in combination with approved capecitabine in the treatment...